← Open Payments lookup

ASHLEY HUITT: Open Payments

NPI 1104462712 · WARREN, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$487 in 23 payments from 10 companies in 2025. Trend: 2023 $308 · 2024 $263 · 2025 $487

Food & beverage: $487
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$149
ABBVIE INC.7$137
Novo Nordisk Inc3$55
Boehringer Ingelheim Pharmaceuticals, Inc.2$41
Otsuka America Pharmaceutical, Inc.1$23
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21
Amgen Inc.1$19
Exact Sciences Corporation1$16
Lilly USA, LLC1$15
Axsome Therapeutics, Inc.1$11

Products named: QULIPTA, AIRSUPRA, VRAYLAR, FARXIGA, JARDIANCE, Ozempic, BREZTRI, REXULTI.

Industry payments across AR — which companies pay providers there.